[HTML][HTML] 不同治疗对肺癌患者血液循环游离DNA 检测EGFR 基因突变的影响及预后分析

苏飞, 郑可, 付祎云, 吴倩, 唐源, 王威亚… - Chinese Journal of …, 2018 - ncbi.nlm.nih.gov
… -therapy, 29 after traditional chemotherapy and 28 after targeted therapy) cases of paired
plasma and tumor tissue specimens, followed by comparing their concordance. The sensitivity, …

[HTML][HTML] 肺癌的个体化靶向治疗

南娟 - Chinese Journal of Lung Cancer, 2013 - ncbi.nlm.nih.gov
由于每一肺癌患者在临床特征、 预后、 治疗反应和耐受性方面的进展都是独特的, 所以肺癌被
认为是异质性疾病。 个体化用药是指运用标志物来预测哪些患者更易获益于某种治疗。 对于肺癌…

[HTML][HTML] EGFR 突变NSCLC 患者TKIs 耐药后ICIs 治疗进展

陈然, 江昌, 马丽, 张树才 - Chinese Journal of Lung Cancer, 2022 - ncbi.nlm.nih.gov
表皮生长因子受体酪氨酸激酶抑制剂( epidermal growth factor receptor-tyrosine kinase inhibitors,
EGFR-TKIs) 耐药后的EGFR 突变晚期非小细胞肺癌( non-small cell lung cancer, NSCLC…

非小细胞肺癌体部寡转移的立体定向放射治疗.

燕相伟, 马洪玉, 刘雪莹, 周源… - Progress in Modern …, 2019 - search.ebscohost.com
Phase II study of stereotactic body radiotherapy to primary … Comparison of four chemotherapy
regimens for advanced non-… trial of stereotactic radiotherapy combined with erlotinib for …

[PDF][PDF] 非小细胞肺癌临床应用免疫营养的研究进展

艾霏儿, 毕清, 汪成洋, 杨晓坤, 周飞 - 肿瘤代谢与营养电子杂志 - 182.92.200.144
… Fish oil effects on quality of life body weight and free fat mass change in gastrointestinal
cancer patients undergoing chemotherapy a triple blind randomized clinical trial J . J Funct …

Orexin-A 在肥胖大鼠摄食和自由活动中的调控.

孙姝, 郭菲菲, 孙向荣, 徐珞, 刘蘅哲… - Progress in Modern …, 2016 - search.ebscohost.com
chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of
two IFCT randomized … A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel …

[PDF][PDF] 不可切除的肝门部胆管癌的治疗进展

李豪, 李发钊, 张瑞之, 陈自然, 戴卫东 - 中国普通外科杂志, 2022 - zpwz.net
… A multicenter randomized phase II study of nivolumab in combination with gemcitabine/cisplatin
or ipilimumab as first-line therapy for patients with advanced unresectable biliary tract …

[PDF][PDF] 维生素C 对乳腺癌细胞紫杉醇化疗的增敏作用

贾国丛, 李阳, 王尧河, 常庆龙, 陈雨婷, 支慧娟 - 中国普通外科杂志, 2017 - zpwz.net
… High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who
have had no prior chemotherapy. A randomized double-blind comparison[J]. N Engl J Med, …

Macrophage Proliferation Machinery Drives Immunosuppression and PDAC Progression (巨噬细胞增值机制抑制肿瘤免疫促进胰腺癌发展)

C Zuo - 2022 - openscholarship.wustl.edu
… To understand the changes in other myeloid cells from p21CE mice, we compared the
numbers of significantly changed genes in each myeloid population between the two genotypes. …

[HTML][HTML] 全身γ 刀治疗中晚期胰腺癌的研究进展

刘智惠, 孙大庆 - 世界华人消化杂志, 2012 - wjgnet.com
胰腺癌是严重威胁人类健康的疾病之一, 但是针对其的有效治疗方法依然非常有限. 本文概述了
国内全身伽玛刀治疗中晚期胰腺癌的原理和疗效等, 简要描述了国外类似的体部立体定向放射…